Migraine: open trials in Japan

• NCT04649242

  Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  Trial Treatment · Phase 3 · Pfizer

  Tennoji Dai Brain Clinic, Abeno-ku Osaka-shi · Konan Medical Center, Higashinada-ku Kobe-shi · Local lndependent Administrative Corporation Hiroshima City Hospital Organization Hiroshima City, Hiroshima · Tanaka Neurosurgery & Headache Clinic, Kagoshima · Ikeda Neurosurgical Clinic, Kasuga-shi · Jinnouchi Neurosurgical Clinic, Kasuga-shi · Hikita Pediatric Clinic, Kiryu-shi · Mito Kyodo General Hospital, Mito · Tominaga Clinic, Naniwa-ku · Yamaguchi Clinic, Nishinomiya-shi · Tokyo Headache Clinic, Shibuya-ku · Tokyo Medical University Hospital, Shinjuku-ku · Sendai Headache and Neurology Clinic, Taihaku-ku Sendai-shi

  Registry updated 2026-10-27

• NCT05156398

  Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  Trial Treatment · Phase 3 · Pfizer

  Tennouji Dai Brain Clinic, Abeno-ku Osaka-shi · Saitama Neuropsychiatric Institute, Chuo-ku Saitama-shi · Konan Medical Center, Higashinada-ku Kobe-shi · Tanaka Neurosurgery & Headache Clinic, Kagoshima · Jinnouchi Neurosurgical Clinic, Kasuga-shi · Hikita Pediatric Clinic, Kiryu-shi · Atago Hospital, Kochi · Mito Kyodo General Hospital, Mito · Tominaga Clinic, Naniwa-ku · Yamaguchi Clinic, Nishinomiya-shi · Tokyo Headache Clinic, Shibuya-ku · Tokyo Medical University Hospital, Shinjuku-ku · Sendai Headache and Neurology Clinic, Taihaku-ku Sendai-shi

  Registry updated 2026-10-14

• NCT06810505

  A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  Trial Treatment · Phase 3 · AbbVie

  Tanaka Neurosurgery & Headache Clinic /ID# 271346, Kagoshima · Nagaseki Headache Clinic /ID# 271699, Kai · Konan Medical Center /ID# 270486, Kobe · Umenotsuji Clinic /ID# 270484, Kochi · Tominaga Clinic - Osaka /ID# 270483, Osaka · Tokyo Headache Clinic /ID# 271610, Shibuya-ku · Tokyo Medical University Hospital /ID# 270487, Shinjuku-ku · Tendo Brain Clinic /ID# 271410, Tendo-shi

  Registry updated 2026-10-09

• NCT05711394

  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Trial Treatment · Phase 3 · AbbVie

  Konan Medical Center /ID# 254457, Kobe · Umenotsuji Clinic /ID# 254453, Kochi · Tatsuoka Neurology Clinic /ID# 254455, Kyoto · Yamaguchi Clinic /ID# 254753, Nishinomiya · Tominaga Clinic - Osaka /ID# 254450, Osaka · Sendai Headache and Neurology Clinic Medical Corporation /ID# 254211, Sendai · Tokyo Medical University Hospital /ID# 254459, Shinjuku-ku

  Registry updated 2026-10-06

• NCT06641466

  A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  Trial Treatment · Phase 3 · Pfizer

  Tanaka Neurosurgery & Headache Clinic, Kagoshima · Tanaka Neurosurgical Clinic, Kagoshima · Nagaseki Headache Clinic, Kai · Konan Medical Center, Kobe · Tatsuoka Neurology Clinic, Kyoto-shi Shimogyo-ku · Sendai Headache and Neurology Clinic, Sendai · Tokyo Headache Clinic, Shibuya-ku

  Registry updated 2026-07-09

• NCT05342493

  Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

  Research · Otsuka Pharmaceutical Co., Ltd.

  Pharmacovigilance Department, Osaka

  Registry updated 2026-06-22

• NCT05707949

  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Trial Treatment · Phase 3 · AbbVie

  Konan Medical Center /ID# 254458, Kobe · Umenotsuji Clinic /ID# 254454, Kochi · Tatsuoka Neurology Clinic /ID# 254456, Kyoto · Yamaguchi Clinic /ID# 254763, Nishinomiya-shi · Tominaga Clinic /ID# 254451, Osaka · Sendai Headache and Neurology Clinic Medical Corporation /ID# 254212, Sendai · Tokyo Medical University Hospital /ID# 254460, Shinjuku-ku

  Registry updated 2025-08-11

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error